PATE1 Human Pre-designed siRNA Set A contains three designed siRNAs for PATE1 gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

PATE2 Human Pre-designed siRNA Set A contains three designed siRNAs for PATE2 gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

PATE3 Human Pre-designed siRNA Set A contains three designed siRNAs for PATE3 gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

PATE4 Human Pre-designed siRNA Set A contains three designed siRNAs for PATE4 gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

PATJ Human Pre-designed siRNA Set A contains three designed siRNAs for PATJ gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

PATL1 Human Pre-designed siRNA Set A contains three designed siRNAs for PATL1 gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

PATL2 Human Pre-designed siRNA Set A contains three designed siRNAs for PATL2 gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

PATZ1 Human Pre-designed siRNA Set A contains three designed siRNAs for PATZ1 gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

PAWR Human Pre-designed siRNA Set A contains three designed siRNAs for PAWR gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

PAX1 Human Pre-designed siRNA Set A contains three designed siRNAs for PAX1 gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

PAX2 Human Pre-designed siRNA Set A contains three designed siRNAs for PAX2 gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

PAX3 Human Pre-designed siRNA Set A contains three designed siRNAs for PAX3 gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

PAX4 Human Pre-designed siRNA Set A contains three designed siRNAs for PAX4 gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

PAX5 Human Pre-designed siRNA Set A contains three designed siRNAs for PAX5 gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

PAX6 Human Pre-designed siRNA Set A contains three designed siRNAs for PAX6 gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

PAX7 Human Pre-designed siRNA Set A contains three designed siRNAs for PAX7 gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

PAX8 Human Pre-designed siRNA Set A contains three designed siRNAs for PAX8 gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

PAX9 Human Pre-designed siRNA Set A contains three designed siRNAs for PAX9 gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

Paxalisib (GDC-0084) is a brain penetrant inhibitor of PI3K and mTOR, with Kis of 2 nM, 46 nM, 3 nM, 10 nM and 70 nM for PI3Kα PI3Kβ, PI3Kδ, PI3Kγ and mTOR, respectively[1].

Paxalisib (GDC-0084) is a brain penetrant inhibitor of PI3K and mTOR, with Kis of 2 nM, 46 nM, 3 nM, 10 nM and 70 nM for PI3Kα PI3Kβ, PI3Kδ, PI3Kγ and mTOR, respectively[1].

Paxalisib (GDC-0084) is a brain penetrant inhibitor of PI3K and mTOR, with Kis of 2 nM, 46 nM, 3 nM, 10 nM and 70 nM for PI3Kα PI3Kβ, PI3Kδ, PI3Kγ and mTOR, respectively[1].

Paxalisib (GDC-0084) is a brain penetrant inhibitor of PI3K and mTOR, with Kis of 2 nM, 46 nM, 3 nM, 10 nM and 70 nM for PI3Kα PI3Kβ, PI3Kδ, PI3Kγ and mTOR, respectively[1].

Paxalisib (GDC-0084) is a brain penetrant inhibitor of PI3K and mTOR, with Kis of 2 nM, 46 nM, 3 nM, 10 nM and 70 nM for PI3Kα PI3Kβ, PI3Kδ, PI3Kγ and mTOR, respectively[1].

Paxalisib (GDC-0084) is a brain penetrant inhibitor of PI3K and mTOR, with Kis of 2 nM, 46 nM, 3 nM, 10 nM and 70 nM for PI3Kα PI3Kβ, PI3Kδ, PI3Kγ and mTOR, respectively[1].

PAXBP1 Human Pre-designed siRNA Set A contains three designed siRNAs for PAXBP1 gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

PAXIP1 Human Pre-designed siRNA Set A contains three designed siRNAs for PAXIP1 gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

PAXX Human Pre-designed siRNA Set A contains three designed siRNAs for PAXX gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

Paynantheine-d3 is a deuterium labeled Paynantheine. Paynantheine is an alkaloid that can be isolated from Mitragyna speciosa. Paynantheine can decrease alcohol intake in mice[1][2].

PBD-monoamide, a modified PBD (pyrrolobenzodiazepine) dimer, is an ADC Cytotoxin. PBD-monoamide can be used for synthesis of DHES0815A (an HER2 ADC). PBD-monoamide has DNA-binding activity and reduces cell viability[1].

PBDC1 Human Pre-designed siRNA Set A contains three designed siRNAs for PBDC1 gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

PBK Human Pre-designed siRNA Set A contains three designed siRNAs for PBK gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

Pbk Mouse Pre-designed siRNA Set A contains three designed siRNAs for Pbk gene (Mouse), as well as a negative control, a positive control, and a FAM-labeled negative control.

Pbk Rat Pre-designed siRNA Set A contains three designed siRNAs for Pbk gene (Rat), as well as a negative control, a positive control, and a FAM-labeled negative control.

PBLD Human Pre-designed siRNA Set A contains three designed siRNAs for PBLD gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

PBRM1 Human Pre-designed siRNA Set A contains three designed siRNAs for PBRM1 gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

PBT434 is a potent, orally active and cross the blood-brain barrier α-synuclein aggregation inhibitor. PBT434 can be used as a iron chelator and modulates transcellular iron trafficking. PBT434 inhibits iron-mediated redox activity and iron-mediated aggregation of α-synuclein. PBT434 prevents the loss of substantia nigra pars compacta neurons (SNpc). PBT434 has the potential for the research […]

PBT434 is a potent, orally active and cross the blood-brain barrier α-synuclein aggregation inhibitor. PBT434 can be used as a iron chelator and modulates transcellular iron trafficking. PBT434 inhibits iron-mediated redox activity and iron-mediated aggregation of α-synuclein. PBT434 prevents the loss of substantia nigra pars compacta neurons (SNpc). PBT434 has the potential for the research […]

PBT434 is a potent, orally active and cross the blood-brain barrier α-synuclein aggregation inhibitor. PBT434 can be used as a iron chelator and modulates transcellular iron trafficking. PBT434 inhibits iron-mediated redox activity and iron-mediated aggregation of α-synuclein. PBT434 prevents the loss of substantia nigra pars compacta neurons (SNpc). PBT434 has the potential for the research […]

PBT434 is a potent, orally active and cross the blood-brain barrier α-synuclein aggregation inhibitor. PBT434 can be used as a iron chelator and modulates transcellular iron trafficking. PBT434 inhibits iron-mediated redox activity and iron-mediated aggregation of α-synuclein. PBT434 prevents the loss of substantia nigra pars compacta neurons (SNpc). PBT434 has the potential for the research […]

PBT434 is a potent, orally active and cross the blood-brain barrier α-synuclein aggregation inhibitor. PBT434 can be used as a iron chelator and modulates transcellular iron trafficking. PBT434 inhibits iron-mediated redox activity and iron-mediated aggregation of α-synuclein. PBT434 prevents the loss of substantia nigra pars compacta neurons (SNpc). PBT434 has the potential for the research […]

PBX-7011 TFA is a derivative of camptothecin (HY-16560), which inhibits expressions of the cancer related survival genes DDX5, Survivin, Mcl-1 and XIAP in cells FaDu, degrades DDX5 proteins and exhibits anticancer activity[1].